A dual modality99mTc/Re(i)-labelled T140 analogue for imaging of CXCR4 expression

2019 ◽  
Vol 17 (3) ◽  
pp. 598-608 ◽  
Author(s):  
William L. Turnbull ◽  
Lihai Yu ◽  
Emily Murrell ◽  
Mark Milne ◽  
Carlie L. Charron ◽  
...  
Keyword(s):  
Fluorescence Microscopy ◽  
Cxcr4 Expression ◽  
Spect Imaging ◽  
Technetium 99M

A T140-derived peptide conjugated with a naphthalimide fluorophore/chelator was coordinated to rhenium or technetium-99m to image CXCR4 expression by fluorescence microscopy or SPECT imaging.

An APD-based iterative reconstruction method for simultaneous technetium-99m/iodine-123 SPECT imaging

2009 ◽  
Vol 25 (4) ◽  
pp. 192-200 ◽  
Author(s):  
S. Shcherbinin ◽  
A. Celler ◽  
M. Trummer ◽  
T. Humphries
Keyword(s):  
Iterative Reconstruction ◽  
Spect Imaging ◽  
Reconstruction Method ◽  
Technetium 99M ◽  
Iodine 123

Improving excretory pathways of technetium-99m SPECT imaging agents based on bioorthogonal Diels-Alder click chemistry

2019 ◽  
Vol 72-73 ◽  
pp. S65
Author(s):  
J. Walsh ◽  
L. Francesconi ◽  
V. Sanders ◽  
D. Iskhakov ◽  
B. Zeglis ◽  
...  
Keyword(s):  
Click Chemistry ◽  
Diels Alder ◽  
Spect Imaging ◽  
Imaging Agents ◽  
Technetium 99M

scholarly journals The Use of Carbon Quantum Dot as Alternative of Stannous Chloride Application in Radiopharmaceutical Kits

2020 ◽  
Vol 2020 ◽  
pp. 1-11
Author(s):  
Seyedeh Masoumeh Ghoreishi ◽  
Atena Najdian ◽  
Sina Yadegari ◽  
Mohammad Seyedhamzeh ◽  
Maziyar Etemadzade ◽  
...  
Keyword(s):  
Nuclear Medicine ◽  
Citric Acid ◽  
Fluorescence Microscopy ◽  
Stannous Chloride ◽  
Optimum Amount ◽  
Technetium 99M ◽  
Carbon Quantum Dot ◽  
Ft Ir ◽  
Unique Chemical ◽  
Reducing Properties

Even today, technetium-99m is a radionuclide choice for diagnostic in nuclear medicine. The unique chemical and physical properties of technetium-99m make it suitable as an available radionuclide in many centers. In this study, we examined the potential of CQD as a reducing agent in the MDP kit. Citric acid-derived CQD was synthesized and confirmed by FT-IR, TEM, UV-Vis, XPS, and surface analysis. No cytotoxicity was observed by the MTT assay. They were reducing properties of the CQD confirmed by fluorescence microscopy. The MDP kit is prepared by evaluating different parameters that affect the radiolabeling yield, including ligand, time, and CQD. The optimum amount of each parameter is obtained by Box–Behnken software. Finally, fluorescent spectroscopy, SPECT imaging, and biodistribution study showed that CQD reduces technetium-99m. Accumulation of radiotracer in the femur showed that CQD could be used in a radiopharmaceutical kit.

A Technetium-99m SPECT Imaging Agent Which Targets the Dopamine Transporter in Primate Brain

1997 ◽  
Vol 40 (12) ◽  
pp. 1835-1844 ◽  
Author(s):  
Peter C. Meltzer ◽  
Paul Blundell ◽  
Alun G. Jones ◽  
Ashfaq Mahmood ◽  
Basem Garada ◽  
...  
Keyword(s):  
Dopamine Transporter ◽  
Spect Imaging ◽  
Imaging Agent ◽  
Technetium 99M ◽  
Primate Brain

New protocol of myocardial SPECT imaging with technetium-99m sestamibi for reducing the time interval between rest and adenosine stress phases

2009 ◽  
Vol 2 (1) ◽  
pp. 70-76 ◽  
Author(s):  
Hajime Monzen ◽  
Masatake Hara ◽  
Akira Nakanishi ◽  
Makoto Hirata ◽  
Takatoshi Suzuki ◽  
...  
Keyword(s):  
Spect Imaging ◽  
Adenosine Stress ◽  
Time Interval ◽  
Myocardial Spect ◽  
Technetium 99M Sestamibi ◽  
Technetium 99M
Sign in / Sign up

Export Citation Format

Share Document